Foundry Partners’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Foundry Partners’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,765	Closed	-$585K	–	442
2020 Q2	$585K	Sell	4,765 -182	-4%	-$20.6K	0.03%	335
2020 Q1	$433K	Hold	4,947	–	–	0.02%	339
2019 Q4	$517K	Sell	4,947 -116	-2%	-$13K	0.02%	345
2019 Q3	$582K	Sell	5,063 -3,919	-44%	-$595K	0.02%	333
2019 Q2	$1.55M	Buy	+8,982	New	+$1.55M	0.06%	288

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Foundry Partners's GWPH Position: Q3 2020 in Review

Foundry Partners sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q3 2020, closing a stake of 4,765 shares — an estimated $585K sold.

Foundry Partners first reported a position in GWPH in Q2 2019 and held it in 5 quarters. The position peaked at $1.55M in Q2 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q3 2020.

Foundry Partners reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q3 2020 after selling out during the quarter.
Foundry Partners sold 4,765 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2020, an estimated $585K.
Foundry Partners first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2019 and held it in 5 quarters.
Foundry Partners's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1.55M in Q2 2019.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2020.

Based on Foundry Partners's 13F filing for Q3 2020, filed 23 Oct 2020.